NCT06540690

Brief Summary

This study aims to characterize and compare the closure of open wounds in the palatal mucosa of diabetic and non-diabetic patients, evaluate clinical, patient-centered and immunological parameters as well as wound microbiome composition.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress81%
Aug 2023Jan 2027

Study Start

First participant enrolled

August 1, 2023

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

August 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 6, 2027

Last Updated

August 6, 2024

Status Verified

January 1, 2024

Enrollment Period

3 years

First QC Date

August 2, 2024

Last Update Submit

August 2, 2024

Conditions

Keywords

PeriodontologyWound healingControlled Clinical TrialDiabetes

Outcome Measures

Primary Outcomes (1)

  • Open Wound Area (OWA)

    For this, standardized photographs will be taken. As a reference, a scale will be used to measure this area. These photographs will be exported to image software (Image J - National Institute of Health -NIH, Bethesda, USA), the area of the wound will be measured in square millimeters (Dias et al. 2015)

    baseline, 7, 14, 21 days after surgery

Secondary Outcomes (12)

  • Tissue Thickness (TT)

    baseline, 90 days after surgery

  • Epithelialization (E)

    baseline, 7, 14, 21, 30 e 90 days after surgery

  • Early wound healing index (EWHI)

    7 and 14 days after surgery

  • Tissue Edema (TE)

    7 days

  • Oral Health Impact Profile (OHIP)

    14 days

  • +7 more secondary outcomes

Study Arms (2)

Diabetic (D)

ACTIVE COMPARATOR

Palatal wound healing in diabetic patients

Procedure: Palatal Wound

Control Group (CG)

ACTIVE COMPARATOR

Palatal wound healing in normoglycemic patients

Procedure: Palatal Wound

Interventions

Palatal WoundPROCEDURE

With the goal to harvest the free gingival graft (FGG), an 8mm diameter scalpel will be used to ensure standardized wounds. Thereafter, a 2-mm thick FGG will be removed. The wound area will receive 4.0 silk sutures.

Control Group (CG)Diabetic (D)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with at least 18 years, systemically healthy, with good oral hygiene, assessed by plaque index and gingival index less than 25% (Ainamo, Bay, 1975);
  • Patients with no morphological or pathological conditions on the palatine donor area;
  • Patients who present indication for extraction and ridge preservation;
  • The tooth included in the study, as well as, the adjacent teeth do not present loss of periodontal insertion;
  • Patients who agreed to and sign the formal consent to participate in the study after receiving an explanation of risks and benefits from an individual who was not a member of the present study (Resolution no. 118 - May, 2012, and Ethics and Code of Professional Conduct in Dentistry - 118/12).
  • Patients diagnosed with type 2 diabetes for more than 5 years who are using oral hypoglycemic agents or insulin supplementation, with HbA1c levels ranging from ≥ 6.1% to 8.5%.
  • Non-diabetic patients with HbA1c levels below 6.1%.

You may not qualify if:

  • Patients with systemic problems (cardiovascular, blood dyscrasias, immunodeficiency, and diabetes, among others) that will contraindicate the surgical procedure;
  • Patients taking medications known to interfere with the wound healing process or that contraindicate the surgical procedure;
  • Smokers patients;
  • Pregnant or lactating patients;
  • Patients who had had periodontal surgery on the study area;
  • Patients who presents opportunistic oral lesions, mainly colonized the palate region;
  • Use of dental prosthesis with palatal cover;
  • Thin palatal mucosa (\~2.0mm).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

College of Dentistry - São José dos Campos, Sao Paulo State University

São José dos Campos, São Paulo, 12245-310, Brazil

RECRUITING

Mauro Pedrine Santamaria and Ana Carolina Ferreira Bonafe

São José dos Campos, São Paulo, 12245000, Brazil

RECRUITING

Related Publications (4)

  • Dias SB, Fonseca MV, Dos Santos NC, Mathias IF, Martinho FC, Junior MS, Jardini MA, Santamaria MP. Effect of GaAIAs low-level laser therapy on the healing of human palate mucosa after connective tissue graft harvesting: randomized clinical trial. Lasers Med Sci. 2015 Aug;30(6):1695-702. doi: 10.1007/s10103-014-1685-2. Epub 2014 Nov 6.

    PMID: 25373688BACKGROUND
  • Kamalathevan P, Ooi PS, Loo YL. Silk-Based Biomaterials in Cutaneous Wound Healing: A Systematic Review. Adv Skin Wound Care. 2018 Dec;31(12):565-573. doi: 10.1097/01.ASW.0000546233.35130.a9.

    PMID: 30475285BACKGROUND
  • Black S, Phillips D, Hickey JW, Kennedy-Darling J, Venkataraaman VG, Samusik N, Goltsev Y, Schurch CM, Nolan GP. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat Protoc. 2021 Aug;16(8):3802-3835. doi: 10.1038/s41596-021-00556-8. Epub 2021 Jul 2.

    PMID: 34215862BACKGROUND
  • Fickl S, Fischer KR, Jockel-Schneider Y, Stappert CF, Schlagenhauf U, Kebschull M. Early wound healing and patient morbidity after single-incision vs. trap-door graft harvesting from the palate--a clinical study. Clin Oral Investig. 2014 Dec;18(9):2213-9. doi: 10.1007/s00784-014-1204-7. Epub 2014 Feb 23.

    PMID: 24562700BACKGROUND

MeSH Terms

Conditions

Wounds and InjuriesDiabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Controlled clinical study, non-randomized, prospective, blinded, with a three-month follow-up.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 2, 2024

First Posted

August 6, 2024

Study Start

August 1, 2023

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

January 6, 2027

Last Updated

August 6, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

Data will be available at the end of the study after a direct request

Shared Documents
STUDY PROTOCOL, ICF

Locations